Analysen zu VINCI
| 25.04.25 | VINCI Buy | Deutsche Bank AG | |
| 24.04.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 24.04.25 | VINCI Outperform | RBC Capital Markets | |
| 22.04.25 | VINCI Buy | Jefferies & Company Inc. | |
| 15.04.25 | VINCI Buy | Jefferies & Company Inc. | |
| 07.04.25 | VINCI Buy | Jefferies & Company Inc. | |
| 07.04.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 31.03.25 | VINCI Buy | Jefferies & Company Inc. | |
| 19.03.25 | VINCI Buy | UBS AG | |
| 18.03.25 | VINCI Buy | Jefferies & Company Inc. | |
| 18.03.25 | VINCI Buy | UBS AG | |
| 17.03.25 | VINCI Kaufen | DZ BANK | |
| 21.02.25 | VINCI Buy | Goldman Sachs Group Inc. | |
| 21.02.25 | VINCI Buy | UBS AG | |
| 18.02.25 | VINCI Buy | UBS AG | |
| 17.02.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 13.02.25 | VINCI Buy | Jefferies & Company Inc. | |
| 12.02.25 | VINCI Buy | UBS AG | |
| 12.02.25 | VINCI Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.02.25 | VINCI Outperform | RBC Capital Markets | |
| 10.02.25 | VINCI Buy | Deutsche Bank AG | |
| 07.02.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | VINCI Buy | Deutsche Bank AG | |
| 07.02.25 | VINCI Buy | Goldman Sachs Group Inc. | |
| 06.02.25 | VINCI Buy | UBS AG | |
| 06.02.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | VINCI Outperform | RBC Capital Markets | |
| 28.01.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 22.01.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 21.01.25 | VINCI Buy | UBS AG | |
| 20.01.25 | VINCI Buy | UBS AG | |
| 09.01.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 08.01.25 | VINCI Buy | Jefferies & Company Inc. | |
| 17.12.24 | VINCI Buy | UBS AG | |
| 12.12.24 | VINCI Outperform | RBC Capital Markets | |
| 27.11.24 | VINCI Buy | Deutsche Bank AG | |
| 25.11.24 | VINCI Outperform | RBC Capital Markets | |
| 25.11.24 | VINCI Buy | Goldman Sachs Group Inc. | |
| 25.11.24 | VINCI Overweight | JP Morgan Chase & Co. | |
| 25.11.24 | VINCI Buy | UBS AG | |
| 22.11.24 | VINCI Outperform | RBC Capital Markets | |
| 22.11.24 | VINCI Buy | Jefferies & Company Inc. | |
| 20.11.24 | VINCI Buy | Jefferies & Company Inc. | |
| 20.11.24 | VINCI Buy | UBS AG | |
| 18.11.24 | VINCI Overweight | JP Morgan Chase & Co. | |
| 14.11.24 | VINCI Buy | UBS AG | |
| 12.11.24 | VINCI Outperform | RBC Capital Markets | |
| 28.10.24 | VINCI Overweight | JP Morgan Chase & Co. | |
| 28.10.24 | VINCI Buy | Goldman Sachs Group Inc. | |
| 28.10.24 | VINCI Buy | UBS AG |
Aktuelle Aktienanalysen
| 08.09.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 08.09.26 | Novartis Sell | Deutsche Bank AG | |
| 08.09.26 | Novartis Hold | Jefferies & Company Inc. | |
| 08.09.26 | EVN kaufen | Erste Group Bank | |
| 08.09.26 | Deutsche Börse Buy | Warburg Research | |
| 08.09.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 08.09.26 | Sanofi Equal Weight | Barclays Capital | |
| 08.09.26 | Roche Overweight | Barclays Capital | |
| 08.09.26 | Sartorius Stedim Biotech Overweight | Barclays Capital | |
| 08.09.26 | Sartorius vz. Overweight | Barclays Capital | |
| 08.09.26 | Novartis Equal Weight | Barclays Capital | |
| 08.09.26 | GSK Underweight | Barclays Capital | |
| 08.09.26 | arGEN-X Overweight | Barclays Capital | |
| 08.09.26 | AstraZeneca Overweight | Barclays Capital | |
| 08.09.26 | Merck Equal Weight | Barclays Capital | |
| 08.09.26 | Bayer Overweight | Barclays Capital | |
| 08.09.26 | BBVA Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | FUCHS Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | Fresenius Buy | UBS AG | |
| 08.09.26 | Commerzbank Neutral | JP Morgan Chase & Co. | |
| 08.09.26 | Deutsche Bank Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | SAP Neutral | UBS AG | |
| 08.09.26 | ASML NV Buy | UBS AG | |
| 08.09.26 | FedEx Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | UniCredit Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | Scout24 Buy | Jefferies & Company Inc. | |
| 08.09.26 | ING Group Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | VINCI Neutral | JP Morgan Chase & Co. | |
| 08.09.26 | Fraport Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.09.26 | Airbus Hold | Jefferies & Company Inc. | |
| 07.09.26 | DWS Group Buy | Jefferies & Company Inc. | |
| 07.09.26 | Unilever Outperform | Bernstein Research | |
| 07.09.26 | L'Oréal Market-Perform | Bernstein Research | |
| 07.09.26 | Danone Outperform | Bernstein Research | |
| 07.09.26 | Henkel vz. Market-Perform | Bernstein Research | |
| 07.09.26 | Nestlé Market-Perform | Bernstein Research | |
| 07.09.26 | Beiersdorf Outperform | Bernstein Research | |
| 07.09.26 | CTS Eventim Outperform | Bernstein Research | |
| 07.09.26 | Volkswagen Market-Perform | Bernstein Research | |
| 07.09.26 | Unilever Hold | Deutsche Bank AG | |
| 07.09.26 | Infineon Buy | Deutsche Bank AG | |
| 07.09.26 | CTS Eventim Buy | Deutsche Bank AG | |
| 07.09.26 | Bechtle Buy | Deutsche Bank AG | |
| 07.09.26 | Nemetschek Buy | Deutsche Bank AG | |
| 07.09.26 | ASOS Equal Weight | Barclays Capital | |
| 07.09.26 | Grand City Properties Neutral | Goldman Sachs Group Inc. | |
| 07.09.26 | LEG Immobilien Neutral | Goldman Sachs Group Inc. | |
| 07.09.26 | Aroundtown Neutral | Goldman Sachs Group Inc. | |
| 07.09.26 | Deutsche Bank Buy | Warburg Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.